Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SONIDEGIB vs VISMODEGIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SONIDEGIB vs VISMODEGIB: Safety Overview

Metric SONIDEGIB VISMODEGIB
Total FAERS Reports 1,411 8,135
Deaths Reported 126 864
Death Rate 8.9% 10.6%
Hospitalizations 253 974
Average Patient Age 70.0 yrs 69.6 yrs
% Female Patients 38.5% 39.3%
FDA Approval Date Jul 24, 2015 Jan 30, 2012
Manufacturer Sun Pharmaceutical Industries, Inc. Genentech, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription